02/12/2024Published by Fondazione Gianni Bonadonna at 02/12/2024Categories Events UncategorizedAnti-PD-L1 plus targeted therapy in anaplastic thyroid carcinoma
25/11/2024Published by Fondazione Gianni Bonadonna at 25/11/2024Categories Events UncategorizedPositive results with inavosilib added to palbociclib and fulvestrant in advanced breast cancer
18/11/2024Published by Fondazione Gianni Bonadonna at 18/11/2024Categories Events UncategorizedDurable response with pemigatinib in cholangiocarcinoma
11/11/2024Published by Fondazione Gianni Bonadonna at 11/11/2024Categories Events UncategorizedA breast cancer Patient-Derived Xenograft biobank to study tumour heterogeneity and mechanisms of resistance
04/11/2024Published by Fondazione Gianni Bonadonna at 04/11/2024Categories Events UncategorizedA new gene expression-based Breast Cancer Purity Score
28/10/2024Published by Fondazione Gianni Bonadonna at 28/10/2024Categories Events UncategorizedA screening of repurposable neuroactive drugs in glioblastoma
21/10/2024Published by Fondazione Gianni Bonadonna at 21/10/2024Categories Events UncategorizedTocilizumab in immune checkpoint inhibitor-associated arthritis
14/10/2024Published by Fondazione Gianni Bonadonna at 14/10/2024Categories Events UncategorizedAtezolizumab added to pertuzumab plus trastuzumab in HER2+ metastatic breast cancer
07/10/2024Published by Fondazione Gianni Bonadonna at 07/10/2024Categories Events UncategorizedTrabectedin added to doxorubicin in advanced leiomyosarcoma
